New research suggests GLP-1 medications like Ozempic and Mounjaro may double the risk of neovascular macular degeneration in diabetic patients, despite benefits for blood sugar control.

The study was a retrospective review of 8,167 neovascular age-related macular degeneration (nAMD) patients receiving continuous, unilateral anti-VEGF therapy for at least 24 months between 2011 ...

A deep learning model may be able to outperform ophthalmologists in predicting neovascular age-related macular degeneration (nAMD) recurrence. Recurrence of neovascular age-related macular ...

Eventually, the NAMD team wants to take 20% or so of the machine for their work, but for now, they are working out what few driver and compiler issues they have hit along the way. The team expects ...

To evaluate the neovascular age-related macular degeneration (nAMD) in patients who were morphologically poor responders to intravitreal ranibizumab (IVR) treatment using indocyanine green ...

Community Case in nAMD This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc. 0.50 CME. 30 MINS. $0 FEE. SAVE. Add topic to email alerts ...

BARCELONA, Spain — Patients who receive a diagnosis of neovascular age-related macular degeneration (nAMD) from their primary care clinician may be less likely to adhere to treatment than those ...

P041, an aflibercept biosimilar, showed noninferiority to originator aflibercept (Eylea) in maintaining vision in nAMD patients over 52 weeks. The study involved 168 patients, with 145 completing ...

Cataract Surgery and nAMD: A Deeper Dive Into Outcomes and Treatment Effects —Cataract surgery significantly improves both distance and near vision in patients with neovascular age-related ...